Particle Testing Authority, Micromeritics’ ISO17025 accredited contract testing laboratory today announced a comprehensive physical characterization service for the additive manufacturing (AM) industry that provides fast and efficient access to the techniques routinely used to optimize process performance and the attributes of finished products.
The Janssen Pharmaceutical Companies of Johnson & Johnson will undertake a significant investment to expand the presence and capabilities of Janssen Research & Development in San Francisco, California.
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company advancing a new class of immunotherapies, today announced that it has entered into multiple collaboration and option agreements with global biotherapeutics leader CSL Behring.
Kramer AG invented and launched the first ever vertical tablet deduster in 1975, the E79, to the world’s pharmaceutical industry to address dusty tablets that caused a great deal of production problems.
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China
In a move to continue expanding our firm’s global presence—and to increase our proximity to key clients—ZS is excited to announce that three new offices will open their doors on Jan. 2, 2020: Seattle, Washington, D.C., and Cambridge, U.K.
Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of innovative cell therapies to treat cancer, today announced plans to open a 90,000 square foot commercial-scale cell therapy manufacturing facility in Singapore by end-2020, which will be one of the leading commercial-scale cell therapy manufacturing facilities in Asia.